Skip to main content

Find Clinical Trials

Home
Conditions
Genetic Diseases, Inborn

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

449 public trials 107 recruiting studies

Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Special Survey for Long Term Application

NCT01516229

Conditions: Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +6 more
Locations: Novo Nordisk Investigational Site Tokyo, Japan

Novo Nordisk Investigational Site Tokyo, Japan

View Trial Details

Completed

Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

NCT01401244

Conditions: Abnormalities, Multiple, Chromosome Disorders, Congenital Abnormalities, +20 more
Locations: Novo Nordisk Investigational Site Evansville, Indiana, United States

View Trial Details

Completed

Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease

NCT00006130

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +23 more
Locations: Children's Hospital of Oakland Oakland, California, United States

University of North Carolina School of Medicine Chapel Hill, North Carolina, United States

View Trial Details

Completed

Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

NCT01529840

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +11 more
Locations: Novo Nordisk Investigational Site Gothenburg, Sweden

View Trial Details

Completed

Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome

NCT01518062

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Chromosome Disorders, +18 more
Locations: Novo Nordisk Investigational Site Alphen aan den Rijn, Netherlands

View Trial Details

Completed

Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration

NCT00362180

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +13 more
Locations: Amsterdam, Netherlands

View Trial Details

Completed

Parental Consanguinity and Family History of Kidney Disease in Turkish Kidney Disease Population

NCT02917070

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hereditary Diseases
Locations: Istanbul University, Istanbul Faculty of Medicine Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia

NCT00477594

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +14 more
Locations: Chicago, Illinois, United States

Auburn, Maine, United States

Biddeford, Maine, United States

Scarborough, Maine, United States

View Trial Details

Completed

Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia

NCT00607373

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +14 more
Locations: Charlotte, North Carolina, United States

Cincinnati, Ohio, United States

São Paulo, Brazil

Chicoutimi, Quebec, Canada

View Trial Details

Completed

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia

NCT00694109

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +14 more
Locations: Mission Viejo, California, United States

Newport Beach, California, United States

Bridgeport, Connecticut, United States

Melbourne, Florida, United States

View all 33 locations

View Trial Details